Technologies
PDF


WARF: P01147US

Automatic Determination of the Arterial Input Function in Dynamic Contrast-Enhanced MRI


INVENTORS -

Timothy Carroll

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing an improved method for automatically determining AIF from MRI images, so it can be used for measuring physiologic quantities such as cerebral blood flow (CBF), which is used in turn to diagnose stroke and other cerebrovascular diseases.
OVERVIEWIschemic stroke is a leading cause of death and disability in industrial nations, accounting for over $30 billion per year in the United States alone. The arterial input function (AIF) is instrumental in calculating physiologic quantities, such as cerebral blood flow (CBF), which in turn are used to diagnose stroke and other cerebrovascular diseases. In treating acute stroke, knowledge of CBF is critical for determining whether to administer thrombolytic agents, which have been shown to improve neurological outcome.

However, these “clot busting” drugs must be administered within three to six hours of the onset of symptoms and incur the risk of fatal cerebral hemorrhage. This makes rapid and reliable diagnosis of salvageable, or “at-risk,” brain tissue critical for determining whether aggressive drug therapy is warranted.

Magnetic resonance imaging (MRI) allows the physician to distinguish between dead and salvageable brain tissue based on CBF. Current methods of measuring CBF using MRI define an AIF chosen from inspection of the MRI images by a trained operator using an iterative “trial and error” approach. Although this approach for defining salvageable tissue is widely used, it requires a dedicated offline workstation and is subject to human error. This may result in a lengthy delay in calculating CBF, which, in turn, may significantly impair, or possibly prevent, the determination of “at-risk” tissue.
THE INVENTIONA UW-Madison researcher has developed a method of automatically determining the AIF from MRI images that eliminates reliance on offline workstations, trained personnel and the lengthy delay normally associated with MRI CBF measurements.
APPLICATIONS
  • Diagnosis and treatment planning for stroke and other cerebrovascular diseases
KEY BENEFITS
  • Allows for rapid triage of acute and hyperacute stroke patients
  • Eliminates the need for trained personnel, dedicated offline workstations, and additional time required to determine cerebral blood (CBF) flow from MRI images
  • Produces an optimal arterial input function (AIF) for calculation of CBF, mean transit time and cerebral blood volume
  • Provides an exceedingly fast and robust method of calculating CBF
ADDITIONAL INFORMATION
Tech Fields
Contact Information
For current licensing status, please contact Jeanine Burmania at jeanine@warf.org or 608-960-9846.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.